Peptide Bβ15-42 preserves endothelial barrier function in shock

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Gröger, Marion ^a   Pasteiner, Waltraud ^b   Ignatyev, George ^c,g   Matt, Ulrich ^d,e   Knapp, Sylvia ^d   Atrasheuskaya, Alena ^c   Bukin, Eugenij ^c   Freidl, Peter ^b   Zinkl, Daniela ^a   Hofer Warbinek, Renate ^e   Zacharowski, Kai ^f   Petzelbauer, Peter ^a   Reingruber, Sonja ^b  

^a Universitatsklinik fur Dermatologie   (Austria)

^b Fibrex Medical Research and Development GmbH   (Austria)

^c STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

^d ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^g MOSCOW AVIATION INSTITUTE NATIONAL RESEARCH UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

FX 06; MYOSIN LIGHT CHAIN; PEPTIDE B BETA[15-42]; PEPTIDE DERIVATIVE; PROTEIN KINASE FYN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; CADHERIN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN BBETA (15 42); FIBRINOGEN BBETA (15-42); FOCAL ADHESION KINASE 1; FYN PROTEIN, MOUSE; LEUKOCYTE ANTIGEN; LIPOPOLYSACCHARIDE; PEPTIDE FRAGMENT; PTK2 PROTEIN, MOUSE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA PROTEIN, MOUSE; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL PNEUMONIA; BLOOD VESSEL PERMEABILITY; CAPILLARY LEAK SYNDROME; CONTROLLED STUDY; DENGUE; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; LUNG EDEMA; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SEPTIC SHOCK; STRESS FIBER; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; CAPILLARY; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; PNEUMONIA; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM;

ANIMALIA; MUS; RATTUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; CADHERINS; CAPILLARIES; DENGUE HEMORRHAGIC FEVER; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FOCAL ADHESION KINASE 1; HUMANS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PNEUMONIA; PROTO-ONCOGENE PROTEINS C-FYN; RATS; RATS, SPRAGUE-DAWLEY; RHO GTP-BINDING PROTEINS; STRESS FIBERS; THROMBIN;

EID: 65549140644     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005391     Document Type: Article

References (51)

1. van Hinsbergh V, van Nieuw Amerongen GP (2002) Intracellular signalling involved in modulating human endothelial barrier function. J Anat 200: 549-560.
2. Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, et al. (2001) Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 345: 408-416.
3. Matsuda N, Hattori Y (2007) Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction. J Smooth Muscle Res 43: 117-137.
4. Petzelbauer P, Zacharowski PA, Miyazaki Y, Friedl P, Wickenhauser G, et al. (2005) The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury. Nat Med 11: 298-304.
5. Sohn RH, Deming CB, Johns DC, Champion HC, Bian C, et al. (2005) Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B. Blood 105: 3910-3917.
6. Vandenbroucke E, Mehta D, Minshall R, Malik AB (2008) Regulation of endothelial junctional permeability. Ann N Y Acad Sci 1123: 134-145.
7. Garcia JG, Davis HW, Patterson CE (1995) Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J Cell Physiol 163: 510-522.
8. Minshall RD, Malik AB (2006) Transport across the endothelium: regulation of endothelial permeability. Handb Exp Pharmacol. pp 107-144.
9. van Nieuw Amerongen GP, Beckers CM, Achekar ID, Zeeman S, Musters RJ, van Hinsberg V (2007) Involvement of Rho kinase in endothelial barrier maintenance. Arterioscler Thromb Vasc Biol 27: 2332-2339.
10. Schaphorst KL, Pavalko FM, Patterson CE, Garcia JG (1997) Thrombin-mediated focal adhesion plaque reorganization in endothelium: role of protein phosphorylation. Am J Respir Cell Mol Biol 17: 443-455.
11. Wu MH (2005) Endothelial focal adhesions and barrier function. J Physiol 569: 359-366.
12. Konstantoulaki M, Kouklis P, Malik AB (2003) Protein kinase C modifications of VE-cadherin, p120, and beta-catenin contribute to endothelial barrier dysregulation induced by thrombin. Am J Physiol Lung Cell Mol Physiol 285: L434-L442.
13. Ukropec JA, Hollinger MK, Salva SM, Woolkalis MJ (2000) SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin. J Biol Chem 275: 5983-5986.
14. Wojciak-Stothard B, Potempa S, Eichholtz T, Ridley AJ (2001) Rho and Rac but not Cdc42 regulate endothelial cell permeability. J Cell Sci 114: 1343-1355.
15. Broman MT, Mehta D, Malik AB (2007) Cdc42 regulates the restoration of endothelial adherens junctions and permeability. Trends Cardiovasc Med 17: 151-156.
16. Dejana E, Spagnuolo R, Bazzoni G (2001) Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration. Thromb Haemost 86: 308-315.
17. Vestweber D (2008) VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 28: 223-232.
18. Bach TL, Barsigian C, Yaen CH, Martinez J (1998) Endothelial cell VE-cadherin functions as a receptor for the beta15-42 sequence of fibrin. J Biol Chem 273: 30719-30728.
19. Gorlatov S, Medved L (2002) Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: mapping of the receptor-binding site in the NH2-terminal portions of the fibrin beta chains. Biochemistry 41: 4107-4116.
20. Fareed J, Hoppensteadt DA, Leya F, Iqbal O, Wolf H, Bick R (1998) Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes. Clin Chem 44: 1845-1853.
21. Roesner JP, Petzelbauer P, Koch A, Mersmann J, Zacharowski PA, et al. (2007) The fibrin-derived peptide Bbeta15-42 is cardioprotective in a pig model of myocardial ischemia-reperfusion injury. Crit Care Med 35: 1730-1735.
22. Atar D, Petzelbauer P, Schwitter J, Huber K, Rensing B, et al. (2009) Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. J Am Coll Cardiol 53: 720-729.
23. Atrasheuskaya A, Petzelbauer P, Fredeking TM, Ignatyev G (2003) Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection. FEMS Immunol Med Microbiol 35: 33-42.
24. Halstead SB (2007) Dengue. Lancet 370: 1644-1652.
25. Srikiatkhachorn A, Krautrachue A, Ratanaprakarn W, Wongtapradit L, Nithipanya N, et al. (2007) Natural history of plasma leakage in dengue hemorrhagic fever: a serial ultrasonographic study. Pediatr Infect Dis J 26: 283-290.
26. Bannerman DD, Goldblum SE (1999) Direct effects of endotoxin on the endothelium: barrier function and injury. Lab Invest 79: 1181-1199.
27. Wills BA, Oragui EE, Stephens AC, Daramola OA, Dung NM, et al. (2002) Coagulation abnormalities in dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with Dengue shock syndrome. Clin Infect Dis 35: 277-285.
28. Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, et al. (2002) Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 185: 1213-1221.
29. Coughlin SR (1999) How the protease thrombin talks to cells. Proc Natl Acad Sci U S A 96: 11023-11027.
30. Parsons JT, Martin KH, Slack JK, Taylor JM, Weed SA (2000) Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene 19: 5606-5613.
31. Brunton VG, MacPherson IR, Frame MC (2004) Cell adhesion receptors, tyrosine kinases and actin modulators: a complex three-way circuitry. Biochim Biophys Acta 1692: 121-144.
32. Ohkawara H, Ishibashi T, Sakamoto T, Sugimoto K, Nagata K, et al. (2005) Thrombin-induced rapid geranylgeranylation of RhoA as an essential process for RhoA activation in endothelial cells. J Biol Chem 280: 10182-10188.
33. Vouret-Craviari V, Boquet P, Pouyssegur J, Van Obberghen-Schilling E (1998) Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function. Mol Biol Cell 9: 2639-2653.
34. Yap AS, Kovacs EM (2003) Direct cadherin-activated cell signaling: a view from the plasma membrane. J Cell Biol 160: 11-16.
35. Noren NK, Arthur WT, Burridge K (2003) Cadherin engagement inhibits RhoA via p190RhoGAP. J Biol Chem 278: 13615-13618.
36. Nelson CM, Pirone DM, Tan JL, Chen CS (2004) Vascular endothelial-cadherin regulates cytoskeletal tension, cell spreading, and focal adhesions by stimulating RhoA. Mol Biol Cell 15: 2943-2953.
37. Beggs HE, Soriano P, Maness PF (1994) NCAM-dependent neurite outgrowth is inhibited in neurons from Fyn-minus mice. J Cell Biol 127: 825-833.
38. van Nieuw Amerongen GP, Natarajan K, Yin G, Hoefen RJ, Osawa M, Haendeler J, et al. (2004) GIT1 mediates thrombin signaling in endothelial cells: role in turnover of RhoA-type focal adhesions. Circ Res 94: 1041-1049.
39. Grant SG, O'Dell TJ, Karl KA, Stein PL, Soriano P, et al. (1992) Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science 258: 1903-1910.
40. Grant SG, Karl KA, Kiebler MA, Kandel ER (1995) Focal adhesion kinase in the brain: novel subcellular localization and specific regulation by Fyn tyrosine kinase in mutant mice. Genes Dev 9: 1909-1921.
41. Stein PL, Lee HM, Rich S, Soriano P (1992) pp59fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell 70: 741-750.
42. Stein PL, Vogel H, Soriano P (1994) Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. Genes Dev 8: 1999-2007.
43. Cobb BS, Schaller MD, Leu TH, Parsons JT (1994) Stable association of pp60src and pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125FAK. Mol Cell Biol 14: 147-155.
44. Schaller MD, Hildebrand JD, Parsons JT (1999) Complex formation with focal adhesion kinase: A mechanism to regulate activity and subcellular localization of Src kinases. Mol Biol Cell 10: 3489-3505.
45. Jimenez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, et al. (2000) Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 6: 41-48.
46. Cary LA, Chang JF, Guan JL (1996) Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J Cell Sci 109(Pt 7): 1787-1794.
47. Liang X, Draghi NA, Resh MD (2004) Signaling from integrins to Fyn to Rho family GTPases regulates morphologic differentiation of oligodendrocytes. J Neurosci 24: 7140-7149.
48. Holinstat M, Knezevic N, Broman M, Samarel AM, Malik AB, et al. (2006) Suppression of RhoA activity by focal adhesion kinase-induced activation of p190RhoGAP: role in regulation of endothelial permeability. J Biol Chem 281: 2296-2305.
49. Bukin EK, Otrashevskaia EV, Vorob'eva MS, Ignat'ev GM (2007) [Comparative study of hemostasis and cytokine production in experimental Dengue virus infection]. Vopr Virusol 52: 32-36.
50. Green TP, Johnson DE, Marchessault RP, Gatto CW (1988) Transvascular flux and tissue accrual of Evans blue: effects of endotoxin and histamine. J Lab Clin Med 111: 173-183.
51. Diamond MS, Edgil D, Roberts TG, Lu B, Harris E (2000) Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol 74: 7814-7823.